Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 4Prostatic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Melanoma 2Lung Neoplasms 2Carcinoma, Intraductal, Noninfiltrating 2Small Cell Lung Carcinoma 1Sarcoma 1Prostate Adenocarcinoma 1Mesothelioma, Malignant 1Lymphatic Metastasis 1Carcinoma, Renal Cell 1Carcinoma, Merkel Cell 1Breast Carcinoma In Situ 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Radiosurgery 2encorafenib 1binimetinib 1alovudine 1Surgical Procedures, Operative 1Radiotherapy, Intensity-Modulated 1Radiation Dose Hypofractionation 1Metastasectomy 1Leuprolide 1Goserelin 1Docetaxel 1DEAE-Dextran 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Lymphatic Metastasis × Radiation Dose Hypofractionation × Clear all
NCT03796767 2026-01-28

SOAR

University of Utah

Phase 2 Active not recruiting
20 enrolled 26 charts
Genitourinary

Lymphatic Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡